Edge Medical Repurchases 152,300 H-Shares, Treasury Stock Now 1.05% of Total Issued Shares

Bulletin Express10-16

Shenzhen Edge Medical Co., Ltd. disclosed that on 16 October 2026 it repurchased 152,300 H-shares on the Hong Kong Stock Exchange at prices ranging from HKD 30.40 to HKD 32.10, representing a volume-weighted average price of HKD 31.06. The total consideration was approximately HKD 4.73 million.

The transaction reduced the company’s outstanding H-shares (excluding treasury shares) by 0.0469%, to 324.31 million. Treasury shares increased to 3.45 million, bringing total issued shares to 327.76 million; treasury stock now accounts for 1.05% of total issued shares.

Since the shareholder mandate granted on 25 June 2026, Edge Medical has repurchased 1.84 million shares, equal to 0.56% of the company’s issued share capital on the mandate date and 5.64% of the 32.61 million shares authorised for buyback.

In line with Hong Kong listing rules, the company is subject to a moratorium on issuing new shares or disposing of treasury shares until 15 November 2026. No repurchased shares have been cancelled to date; all remain held in treasury.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment